These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 18410569

  • 1. Current status of globin gene therapy for the treatment of beta-thalassaemia.
    Lisowski L, Sadelain M.
    Br J Haematol; 2008 May; 141(3):335-45. PubMed ID: 18410569
    [Abstract] [Full Text] [Related]

  • 2. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M.
    Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
    [Abstract] [Full Text] [Related]

  • 3. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M, Lisowski L, Samakoglu S, Rivella S, May C, Riviere I.
    Ann N Y Acad Sci; 2005 May; 1054():78-91. PubMed ID: 16339654
    [Abstract] [Full Text] [Related]

  • 4. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
    Sadelain M, Rivella S, Lisowski L, Samakoglu S, Rivière I.
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
    [Abstract] [Full Text] [Related]

  • 5. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P, Arumugam PI, Yee JK, Puthenveetil G.
    Ann N Y Acad Sci; 2005 Sep; 1054():238-49. PubMed ID: 16339671
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.
    May C, Rivella S, Callegari J, Heller G, Gaensler KM, Luzzatto L, Sadelain M.
    Nature; 2000 Jul 06; 406(6791):82-6. PubMed ID: 10894546
    [Abstract] [Full Text] [Related]

  • 7. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
    Bank A, Dorazio R, Leboulch P.
    Ann N Y Acad Sci; 2005 Jul 06; 1054():308-16. PubMed ID: 16339679
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic globin gene delivery using lentiviral vectors.
    Rivella S, Sadelain M.
    Curr Opin Mol Ther; 2002 Oct 06; 4(5):505-14. PubMed ID: 12435053
    [Abstract] [Full Text] [Related]

  • 9. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M, Qing K, Zhou S, Yoder MC, Srivastava A.
    Mol Ther; 2001 Jun 06; 3(6):940-6. PubMed ID: 11407908
    [Abstract] [Full Text] [Related]

  • 10. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
    Li W, Xie S, Guo X, Gong X, Wang S, Lin D, Zhang J, Ren Z, Huang S, Zeng F, Zeng Y.
    Haematologica; 2008 Mar 06; 93(3):356-62. PubMed ID: 18268280
    [Abstract] [Full Text] [Related]

  • 11. In vivo silencing of the human gamma-globin gene in murine erythroid cells following retroviral transduction.
    Lung HY, Meeus IS, Weinberg RS, Atweh GF.
    Blood Cells Mol Dis; 2000 Dec 06; 26(6):613-9. PubMed ID: 11358353
    [Abstract] [Full Text] [Related]

  • 12. Hemoglobin gene therapy for β-thalassemia.
    Bank A.
    Hematol Oncol Clin North Am; 2010 Dec 06; 24(6):1187-201. PubMed ID: 21075288
    [Abstract] [Full Text] [Related]

  • 13. Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells.
    Oh IH, Fabry ME, Humphries RK, Pawliuk R, Leboulch P, Hoffman R, Nagel RL, Eaves C.
    Exp Hematol; 2004 May 06; 32(5):461-9. PubMed ID: 15145214
    [Abstract] [Full Text] [Related]

  • 14. Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin.
    Nishino T, Tubb J, Emery DW.
    Blood Cells Mol Dis; 2006 May 06; 37(1):1-7. PubMed ID: 16814578
    [Abstract] [Full Text] [Related]

  • 15. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
    Xie SY, Ren ZR, Zhang JZ, Guo XB, Wang QX, Wang S, Lin D, Gong XL, Li W, Huang SZ, Zeng F, Zeng YT.
    Hum Mol Genet; 2007 Nov 01; 16(21):2616-25. PubMed ID: 17716993
    [Abstract] [Full Text] [Related]

  • 16. Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in beta-thalassemia.
    Sadelain M, Rivière I, Wang X, Boulad F, Prockop S, Giardina P, Maggio A, Galanello R, Locatelli F, Yannaki E.
    Ann N Y Acad Sci; 2010 Aug 01; 1202():52-8. PubMed ID: 20712772
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing.
    Rivella S, Sadelain M.
    Semin Hematol; 1998 Apr 01; 35(2):112-25. PubMed ID: 9565154
    [Abstract] [Full Text] [Related]

  • 19. Gene therapy for hemoglobinopathies: are we there yet?
    Puthenveetil G, Malik P.
    Curr Hematol Rep; 2004 Jul 01; 3(4):298-305. PubMed ID: 15217560
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.